Charles Olson

Charles V.
Olson currently serves as Independent Director at Edesa Biotech, Inc. since 2023, President at Alkira Therapeutics, Inc., and Senior Vice President-Technical Operations at NervGen Pharma Corp.
Former positions include Director-Manufacturing Sciences at Onyx Pharmaceuticals, Inc., Senior Director-Manufacturing at BioMarin Pharmaceutical, Inc., Independent Director at Stellar Biotechnologies, Inc. from 2016 to 2019, Vice President-Hayward Operations at Cell Genesys, Inc., Chief Operating Officer at Dendreon Corp.
from 2021 to 2023, Chief Technology Officer at Anthera Pharmaceuticals, Inc. from 2016 to 2017, Vice President-CMC & Technical Operations at NGM Biopharmaceuticals, Inc., Senior Vice President-Product & Operations at Ansun Biopharma, Inc., and Senior Vice President-Operations at Applied Molecular Transport, Inc. from 2019 to 2022.
Education includes graduate studies at the University of California, Santa Barbara, undergraduate studies at Westmont College, and a doctorate from Hawthorn University.